N Vad - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

N Vad

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Ugeskrift for Laeger|February 13, 1984

[Protruding ears. A modified Stenström/Warrer plastic technic]F Nielsen, S Kristensen, N Vad

Leukemia|September 20, 2014

MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.

Leukemia|June 26, 2015

Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomibS Jagannathan, M A Y Abdel-Malek, E Malek, et al.

Leukemia|September 29, 2016

Pharmacogenomics and chemical library screens reveal a novel SCF<sup>SKP2</sup> inhibitor that overcomes Bortezomib resistance in multiple myelomaE Malek, M A Y Abdel-Malek, S Jagannathan, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Ugeskrift for Laeger|February 13, 1984

[Protruding ears. A modified Stenström/Warrer plastic technic]F Nielsen, S Kristensen, N Vad

Leukemia|September 20, 2014

MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.

Leukemia|June 26, 2015

Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomibS Jagannathan, M A Y Abdel-Malek, E Malek, et al.

Leukemia|September 29, 2016

Pharmacogenomics and chemical library screens reveal a novel SCF<sup>SKP2</sup> inhibitor that overcomes Bortezomib resistance in multiple myelomaE Malek, M A Y Abdel-Malek, S Jagannathan, et al.

Pageof 1